World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
62
Citations
14835
World Ranking
3126
National Ranking
1463

Dean A. Lee publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Dean A. Lee sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 355 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Dean A. Lee D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Dean A. Lee sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 62 D-Index — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Dean A. Lee is affiliated with Nationwide Children's Hospital in the United States. The research primarily focuses on immune cell function, especially natural killer (NK) cells, and their applications in cancer and hematologic malignancies. Their body of work explores the roles and therapies involving NK cells, hematopoietic stem cell transplantation, and CAR-T cell therapy.

Frequent coauthors who have collaborated extensively with Dean A. Lee include Mitchell S. Cairo, Yaya Chu, Janet Ayello, Gregory K. Behbehani, and Meisam Naeimi Kararoudi.

Dean A. Lee has contributed to multiple publication venues with recurring appearances in Blood, Transplantation and Cellular Therapy, Cancer Research, Regular and Young Investigator Award Abstracts, and Molecular Therapy Oncology.

Their main fields of study cover Medicine and Immunology and Microbiology. Subfields include Immunology, Oncology, Molecular Biology, Hematology, and Genetics.

Main research topics associated with Dean A. Lee are:

  • Immune Cell Function and Interaction
  • CAR-T cell therapy research
  • Hematopoietic Stem Cell Transplantation
  • Virus-based gene therapy research
  • Acute Myeloid Leukemia Research
  • T-cell and B-cell Immunology
  • Neuroblastoma Research and Treatments

Recent notable papers authored or coauthored by Dean A. Lee include:

  • NKG2D-CAR-transduced natural killer cells efficiently target multiple myeloma, 2021, Blood Cancer Journal
  • CD38 deletion of human primary NK cells eliminates daratumumab-induced fratricide and boosts their effector activity, 2020, Blood
  • Decrease post-transplant relapse using donor-derived expanded NK-cells, 2021, Leukemia
  • Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymoma, 2020, Neuro-Oncology
  • Natural killer cell therapy for hematologic malignancies: successes, challenges, and the future, 2021, Stem Cell Research & Therapy

Best Publications

  • Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells

    Cecele J. Denman;Vladimir V. Senyukov;Srinivas S. Somanchi;Prasad V. Phatarpekar

  • Tumor-Specific Human CD4+ Regulatory T Cells and Their Ligands: Implications for Immunotherapy

    Helen Yicheng Wang;Dean A. Lee;Guangyong Peng;Zhong Guo

  • A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR.

    Hiroki Torikai;Andreas Reik;Pei Qi Liu;Yuanyue Zhou

  • Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells

    Partow Kebriaei;Harjeet Singh;M. Helen Huls;Matthew J. Figliola

  • New insights to the MLL recombinome of acute leukemias

    C. Meyer;E. Kowarz;J. Hofmann;A. Renneville

  • Tethered IL-15 augments antitumor activity and promotes a stem-cell memory subset in tumor-specific T cells.

    Lenka V. Hurton;Lenka V. Hurton;Harjeet Singh;Amer M. Najjar;Kirsten C. Switzer

  • Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy

    David A. Knorr;Zhenya Ni;David L Lampi Hermanson;Melinda K. Hexum

  • Tuning Sensitivity of CAR to EGFR Density Limits Recognition of Normal Tissue While Maintaining Potent Antitumor Activity

    Hillary G. Caruso;Hillary G. Caruso;Lenka V. Hurton;Lenka V. Hurton;Amer Najjar;David Rushworth;David Rushworth

  • Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation.

    Stefan O. Ciurea;Jolie R. Schafer;Roland Bassett;Cecele J. Denman

  • Toward eliminating HLA class I expression to generate universal cells from allogeneic donors

    Hiroki Torikai;Andreas Reik;Frank Soldner;Edus H. Warren

  • T cells redirected to EphA2 for the immunotherapy of glioblastoma.

    Kevin Kh Chow;Swati Naik;Sunitha Kakarla;Vita S. Brawley

  • Similar transplantation outcomes for acute myeloid leukemia and myelodysplastic syndrome patients with haploidentical versus 10/10 human leukocyte antigen-matched unrelated and related donors.

    Antonio Di Stasi;Denái R. Milton;L.M. Poon;Amir Hamdi

  • Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection

    Pappanaicken R. Kumaresan;Pallavi R. Manuri;Nathaniel D. Albert;Sourindra Maiti

  • Reprogramming CD19-Specific T Cells with IL-21 Signaling Can Improve Adoptive Immunotherapy of B-Lineage Malignancies

    Harjeet Singh;Matthew J. Figliola;Margaret J. Dawson;Helen Huls

  • Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma.

    Nina Shah;Li Li;Jessica McCarty;Indreshpal Kaur

  • Antigen Presenting Cell-Mediated Expansion of Human Umbilical Cord Blood Yields Log-Scale Expansion of Natural Killer Cells with Anti-Myeloma Activity

    Nina Shah;Beatriz Martin-Antonio;Hong Yang;Stephanie Ku

  • Bispecific T-cells Expressing Polyclonal Repertoire of Endogenous γδ T-cell Receptors and Introduced CD19-specific Chimeric Antigen Receptor

    Drew C Deniger;Kirsten Switzer;Tiejuan Mi;Sourindra Maiti

  • Autologous bone marrow mononuclear cell therapy for severe traumatic brain injury in children.

    Charles S. Cox;James E. Baumgartner;Matthew T. Harting;Laura L. Worth

  • Chimeric Antigen Receptor (CAR)-Specific Monoclonal Antibody to Detect CD19-Specific T Cells in Clinical Trials

    Bipulendu Jena;Sourindra Maiti;Helen Huls;Harjeet Singh

  • Expansion, purification, and functional assessment of human peripheral blood NK cells.

    Srinivas S. Somanchi;Vladimir V. Senyukov;Cecele J. Denman;Dean A. Lee

Frequent Co-Authors

Laurence J.N. Cooper
Laurence J.N. Cooper The University of Texas MD Anderson Cancer Center
Richard E. Champlin
Richard E. Champlin The University of Texas MD Anderson Cancer Center
Elizabeth J. Shpall
Elizabeth J. Shpall The University of Texas MD Anderson Cancer Center
Partow Kebriaei
Partow Kebriaei The University of Texas MD Anderson Cancer Center
Mitchell S. Cairo
Mitchell S. Cairo New York Medical College
Hing C. Wong
Hing C. Wong Georgia State University
Katayoun Rezvani
Katayoun Rezvani The University of Texas MD Anderson Cancer Center
Catherine M. Bollard
Catherine M. Bollard George Washington University
Ali A. Ashkar
Ali A. Ashkar McMaster University
Perry B. Hackett
Perry B. Hackett University of Minnesota

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can broaden career opportunities. For example, an accelerated FNP program enables registered nurses to specialize as family nurse practitioners, blending clinical expertise with immunological knowledge.

If you’re starting without a nursing background, enrolling in one of the best online BSN programs for non nurses provides a solid foundation in patient care and scientific principles crucial to understanding immunology in practice.

For a quicker pathway into nursing, considering the easiest ABSN programs to get into can be a strategic choice. These programs often have more flexible admission criteria, which may appeal to students seeking to advance their healthcare careers efficiently.

Additionally, LPN programs with easiest admission requirements offer entry-level opportunities to work closely with patients while gaining experience that can support further specialization in immunology-related fields later on.

Best Scientists Citing Dean A. Lee

Trending Scientists

Recently Published Articles